Archives for July 11, 2018

DIA 2018

Clinical technology is broken, so what is being done to fix it?

The need to improve visibility, enable faster study execution, and improve study quality, is driving the industry to unify its "broken" clinical trial operating environments, according to a report.

Warning, recall, alert: Unsanitary lab conditions raise US FDA alarm

An inspection of Ranier’s Compounding Laboratory has revealed poor sterile production practices, says the US FDA.

AcuraStem targets small molecule ALS market

AcuraStem has received $3.7m to develop a small molecule treatment for amyotrophic lateral sclerosis (ALS), which it says could compete with Sanofi’s Riluzole and Mitsubishi Tanabe’s Radicava.

Two US patents will help deliver ketamine-like antidepressant effects, says VistaGen

The US Patent and Trademark Office (USPTO) has granted two patents related to VistaGen Therapeutics’ lead asset AV-101, an oral candidate designed to treat CNS diseases and disorders.

Elite Pharma: Eyes on Troxyca, but Pfizer blocking generic release

Pfizer’s decision to discontinue abuse-deterrent Troxyca ER is “effectively stopping us from entering the market,” says Elite CEO.